Real Estate · Real Estate Investment Trusts

NHI NATIONAL HEALTH INVESTORS INC SEC Filings & Insider Trading Activity 2026

company
CIK 877860135 filings
Russell 2000

NHI at a glance

NATIONAL HEALTH INVESTORS INC (NHI, SEC CIK 877860) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 13, 2026 and Form 4 insider filings as recently as November 18, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), NATIONAL HEALTH INVESTORS INC (NHI) reported revenue of $80.1 million (up 47.1% from FY2024) and net income of $142.2 million. Diluted EPS was $3.02.
  • As of September 30, 2026, 30 institutional investment managers tracked by SignalX reported holding NATIONAL HEALTH INVESTORS INC (NHI) shares worth $1.8 billion in 13F-HR filings.
  • The most recent insider open-market purchase reported on Form 4 was by Mendelsohn D. Eric on November 17, 2026 of 1,500 shares at $60.53 per share.
  • In the last 90 days, NHI insiders reported 1 open-market purchase ($91K) and 0 open-market sales ($0) on Form 4, a net purchase of $91K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$80.1M
+47.1% vs prior year
Insiders · 90 days
1 buy · 0 sells
Net +$91K
13F holders
30 funds
$1.8B · +0 vs prior quarter
Latest 8-K
Nov 13, 2026
Item 5.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business model: Investment in healthcare real estate and selective investments in healthcare operators
  • New emphasis on CMS final rule (Nov 2023) requiring Medicare/Medicaid SNFs to disclose ownership details publicly, increasing scrutiny on REITs and private equity
  • Strategic risk focus on rising liability insurance costs and litigation exposure, including increased SNF liability claims and insurance restrictions in Texas and Florida
  • Notable metric: Resident loan balance secured by Timber Ridge property at $7.7 million as of December 31, 2025, highlighting operational complexity of RIDEA joint venture
  • Unusual fact: Potential material adverse impact if Timber Ridge OpCo consolidation is required, due to accounting treatment of refundable entrance fees under Type A CCRC model

Risk Factors

  • Regulatory risk from recent tax law OBBBA effective 2025; increases REIT TRS asset test from 20% to 25% and affects interest deduction limits
  • Geopolitical/macro risk: Exposure to operators under financial distress, e.g., Bickford’s non-performing mezzanine loan of $1.3M and going concern doubts
  • Operational vulnerability: Reliance on third-party managers for SHOP segment operations, dependent on their personnel/resources and regulatory compliance
  • Competitive risk: Lease renewal uncertainty with NHC, a major tenant of 32 SNFs and 3 ILFs, currently in default on non-monetary lease provisions
  • Financial risk: Tenant concentration with Senior Living group accounting for 14.7% of revenues and $9M outstanding revolving credit as of 12/31/2025

Management Discussion & Analysis

  • No forward-looking guidance or risk disclosures available in excerpt

AI summary of the NHI 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes identified in provided Risk Factors section, which contains no substantive risk-factor disclosures
  • Regulatory risk: Section 1031 eligibility period expires December 28, 2026 for $336.3 million of remaining sale proceeds
  • Operational risk: Bickford’s ability to continue as a going concern remained uncertain as of September 30, 2026
  • Financial risk: $100.0 million private placement note matures in January 2027
  • Concentration risk: Senior Living generated $42.6 million, or 12.2% of total revenues, during nine months ended September 30, 2026

Management Discussion & Analysis

  • Revenue $113.5M, up 26.3% YoY from $89.8M, driven by resident fees and services of $47.7M
  • Net income $563.2M vs $32.5M, including $542.7M of disposition gains from the NHC portfolio sale
  • SHOP best-performing segment: NOI $11.5M vs $4.9M YoY; Real Estate Investments NOI $63.0M vs $66.1M
  • Cash, equivalents and restricted cash $278.3M vs $81.6M; operating cash flow $166.4M vs $168.8M
  • Outlook: $497.0M Credit Facility availability; $107.7M SHOP acquisition and $16.8M ALF purchase completed in October 2026

AI summary of the NHI 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 13, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • NHI entered indemnification agreements with all directors and certain officers, including executive officers, on November 9, 2026
  • Broad protection for legal expenses and liabilities arising from service, to the maximum extent permitted under Maryland law
Filed Nov 9, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Earnings release covers the quarter ended September 30, 2026
  • Exhibit 99.1 contains National Health Investors’ quarterly financial results and management commentary

Item EX-99.1: Item EX-99.1

  • Q3 normalized FFO per share fell 15.2% to $1.12, signaling weaker recurring earnings despite portfolio expansion
  • Net income surged to $11.47 per share, driven by the $541.6 million NHC portfolio sale gain, not operations
Filed Nov 9, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Supplemental Information for quarter ended September 30, 2026, providing investors with additional operating and financial data
  • Exhibit 99.1 contains the detailed supplemental package

Item EX-99.1: Item EX-99.1

  • Q3 2026 supplemental reports annualized adjusted NOI of $292.6 million from contracts in place
  • Real estate investments generated annualized adjusted NOI of $246.5 million, with $226.3 million in annualized cash lease revenue

AI summaries of NHI 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for NHI

Don't miss the next NHI filing

  • Alerts as it files. A push when NHI files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut NHI, by share count.
  • Ask anything. An AI agent that reads every NHI filing and answers with sources.

NHI alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Mendelsohn D. EricBuyNov 17, 2026$60.53
Maingot Christian KenAJul 27, 2026-
MCCABE ROBERT A JRBuyJun 15, 2026$71.65
Mendelsohn D. EricBuyJun 5, 2026$68.84
Jobe James RGJun 5, 2026-
Mendelsohn D. EricFMay 5, 2026$73.09
Spaid John LFMay 5, 2026$73.09
Travis David LFMay 5, 2026$73.09

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue$48.8M$54.4M$80.1M
Net Income$135.7M$138.0M$142.2M
Net Margin277.9%253.6%177.6%
Balance Sheet
Total Assets-$2.6B$2.8B
Equity$1.3B$1.4B$1.5B
ROE10.8%10.1%9.3%
Per Share
EPS$3.13$3.13$3.02
Cash Flow
Operating CF$184.4M$207.8M$236.6M
CapEx$49.6M$157.9M$294.0M

Source: XBRL data in NATIONAL HEALTH INVESTORS INC (NHI)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate NHI share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
NHI shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202630$1.79B
Q2 202630$2.04B
Q1 202632$1.78B
Q4 202528$1.62B
Q3 202529$1.85B
Q2 202531$1.46B
Q1 202527$1.07B
Q4 202423$928.1M
Position changes: Q2 2026 → Q3 2026
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 230 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

NHI filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 18, 2026--
8-KNov 13, 2026Analysis-
10-QNov 9, 2026Analysis
8-KNov 9, 2026Analysis-
8-KNov 9, 2026Analysis-
8-KNov 9, 2026Analysis-
8-KAug 27, 2026Analysis-
8-KAug 10, 2026Analysis-
8-KAug 10, 2026Analysis-
8-KAug 10, 2026Analysis-
10-QAug 10, 2026Analysis
SC 13GAug 7, 2026-
4Jul 30, 2026--
8-KJul 27, 2026Analysis-
8-KJul 1, 2026Analysis-
8-KJul 1, 2026Analysis-
4Jun 15, 2026--
4Jun 9, 2026-
4Jun 5, 2026-
8-KJun 1, 2026Analysis
8-KMay 29, 2026-
4May 7, 2026-
4May 7, 2026-
4May 7, 2026-
10-QMay 4, 2026Analysis

Related Real Estate companies

All Real Estate →

NHI SEC filings: frequently asked questions

Are NHI insiders buying or selling?

In the last 90 days, NATIONAL HEALTH INVESTORS INC (NHI) officers, directors and 10% owners reported 1 open-market purchase worth $90,795 by 1 insider and no open-market sales on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold NHI stock?

As of September 30, 2026, the largest NATIONAL HEALTH INVESTORS INC (NHI) holders among the 13F filers tracked by SignalX were BlackRock ($573.3 million), Vanguard Portfolio Management LLC ($314.0 million), State Street Corp ($186.1 million), Vanguard Capital Management LLC ($145.5 million), Principal Financial Group ($131.1 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was NHI's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), NATIONAL HEALTH INVESTORS INC (NHI) reported revenue of $80.1 million (up 47.1% from FY2024) and net income of $142.2 million. Diluted EPS was $3.02. The figures come from the XBRL data in the 10-K.

What are the main risks in NHI's latest 10-K?

In the 10-K filed February 26, 2026, NATIONAL HEALTH INVESTORS INC (NHI) flagged: Regulatory risk from recent tax law OBBBA effective 2025; increases REIT TRS asset test from 20% to 25% and affects interest deduction limits. Geopolitical/macro risk: Exposure to operators under financial distress, e.g., Bickford’s non-performing mezzanine loan of $1.3M and going concern doubts. (AI summary of the Risk Factors section.)

What did NHI report in its latest 8-K?

NATIONAL HEALTH INVESTORS INC (NHI) filed an 8-K on November 13, 2026 reporting Item 5.02 (Departure/Appointment of Directors or Principal Officers). NHI entered indemnification agreements with all directors and certain officers, including executive officers, on November 9, 2026.

What are the latest NHI SEC filings?

NATIONAL HEALTH INVESTORS INC (NHI) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 13, 2026 and a Form 4 insider filing on November 18, 2026.

What is NHI's SEC CIK number?

NATIONAL HEALTH INVESTORS INC (NHI)'s SEC Central Index Key (CIK) is 877860. EDGAR lists every NHI filing under that number.

Ask anything about NHI

The research agent reads NHI's filings, financials, insider trades and 13F holders, then answers with sources.